Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-361-9 | CAS number: 18479-57-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No experimental toxico-kinetic data are available for assessing adsorption, distribution, metabolisation and excretion of the substance. Based on effects seen in the human health toxicity studies and physico-chemical parameters Tetrahydromyrcenol is expected to be readily absorbed via the oral and inhalation route and somewhat lower via the dermal route. Using the precautionary principle for route to route extrapolation the final absorption percentages derived are: 50% oral absorption, 50% dermal absorption and 100% inhalation absorption.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
Toxico-kinetic behaviour of Tetrahydromyrcenol
Introduction
Tetrahydromyrcenol Cas no18479-57-7) has a branched alkyl chain back bone to which a tertiairy alcohol is attached. This tertiairy alcohol is thefunctional group. It is liquid with a molecular weight of 158 that does not preclude absorption. The test material is unlikely to hydrolyse because there are no hydrolysable groups (e.g. such as esters). The substance has a low volatility of 9.3 Pa.
Absorption
Oral:The results of the repeat dose oral toxicity of the analogue Dihydromyrcenol show that the substance is being absorbed by the gastro-intestinal tract following oral administration, because some liver and kidney effects were seen. The relatively low molecular weight (158) and the moderate octanol/water partition coefficient (Log Kow 3.2) and water solubility (282 mg/l) would favour absorption through the gut. According to Martinez and Amidon (2002) the optimal log Kow for oral absorption falls within a range of 2-7. This shows that the substance is likely to be absorbed orally and therefore the oral absorption is expected to be much > 50% but 50% will be used as a default value.
Skin: Based on the substance having a molecular weight of 158, being a liquid, the physico-chemical characteristics of the substance, log Kow (3.2) and water solubility (282), indicate that dermal absorption is likely to occur. The optimal MW and log Kow for dermal absorption is < 100 and in the range of 1-4, respectively (ECHA guidance, 7.12, Table R.7.12-3). The molecular weight of the substance is just outside optimal range and therefore the skin absorption is expected to be similar to oral absorption but will not exceed this. Therefore 50% will be used as a default value.
Lungs: Absorption via the lungs is also indicated based on these physico-chemical properties. Though the inhalation exposure route is thought minor, because of its low volatility (9.3 Pa), the octanol/water partition coefficient (3.2), indicates that inhalation absorption is possible. The blood/air (BA) partition coefficient is another partition coefficient indicating lung absorption. Buist et al. 2012 have developed BA model for humans using the most important and readily available parameters:
Log PBA = 6.96 – 1.04 Log (VP) – 0.533 (Log) Kow – 0.00495 MW.
ForThe substancethe B/A partition coefficient would result in:
Log P (BA) = 6.96 – 1.04 Log (9.3)– 0.533*3.2 – 0.00495*158 = 3.47
This means that the substance has a tendency to go from air into the blood. It should, however, be noted that this regression line is only valid for substances which have a vapour pressure > 100 Pa. Despite the substance being somewhat out of the applicability domain and the exact B/A may not be fully correct, it can be seen that the substance will be readily absorbed via the inhalation route and will be close to 100%.
Distribution
The moderate water solubility (282) of the test substance may present some distribution in the body via the water channels. The log Kow (3.2) would suggest that the substance would pass through the biological cell membrane. In view of this log Kow the substance as such would not accumulate in the body fat.
Metabolism
There are no actual data on the metabolisation of the substance but the anticipated metabolism using OECD Toolbox is summarized in Fig. 1, which is in accordance with Belsito review on non-cyclic terpene alcohols (Belsito et al., 2010). During Phase 1 metabolism, the methyl C atoms may become oxidized towards primary alcohols which may further oxidise into acids. During Phase 2 metabolism these alcohols can be conjugated by glucuronation. It is also anticipated that in the lysosomes the alcohol become conjugated with alpha2u-globulins.
Fig. 1 The metabolisation pathway of the substance as summarized from OECD Toolbox.
Excretion
In view of the anticipated higher water solubility of the metabolites the kidney is the main route of excretion. Alpha2u-globulin precipitation is seen in male rats causing alpha-hydrocarbon nephropathy indicate also that the kidney is the main route of excretion. Acidic metabolites may also be excreted as such.
Discussion
Tetrahydromyrcenol is expected to be readily absorbed, orally and via inhalation, based on the human toxicological information and physico-chemical parameters. The substance also is expected to be absorbed dermally based on the physic-chemical properties. The MW and the log Kow are higher than the favourable range for dermal absorption but significant absorption is likely.
In view of the absence of adverse effect in the repeated dose / reproscreen study route to route extrapolation is not needed.
Conclusion
Tetrahydromyrcenol is expected to be readily absorbed via the oral and inhalation route and somewhat lower via the dermal route based on toxicity and physico-chemical data. Using the precautionary principle for route to route extrapolation the final absorption percentages derived are: 50% oral absorption, 50% dermal absorption and 100% inhalation absorption.
References
D. Belsito, D. Bickers, M. Bruze, P. Calow, H. Greim, J.M. Hanifin, A.E. Rogers, J.H. Saurat,
I.G. Sipes, H. Tagami: The RIFM Expert Panel. A safety assessment of branched chain saturated alcohols when used as fragrance ingredients. Food and Chemical Toxicology 48 (2010) S1–S46
Buist, H.E., Wit-Bos de, L., Bouwman, T., Vaes, W.H.J., 2012, Predicting blood:air partion coefficient using basis physico-chemical properties, Regul. Toxicol. Pharmacol., 62, 23-28.
Martinez, M.N., And Amidon, G.L., 2002, Mechanistic approach to understanding the factors affecting drug absorption: a review of fundament, J. Clinical Pharmacol., 42, 620-643.
IGHRC, 2006, Guidelines on route to route extrapolation of toxicity data when assessing health risks of chemicals,http://ieh.cranfield.ac.uk/ighrc/cr12[1].pdf
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.